94 related articles for article (PubMed ID: 85897)
1. Is microcrystalline theophylline really better?
Apold J; Bakke OM
Lancet; 1979 Mar; 1(8117):667-8. PubMed ID: 85897
[No Abstract] [Full Text] [Related]
2. Forty-eight-hour absorption pharmacokinetic profiles of two sustained-release theophylline preparations.
Green LD; Saccar CL; Helsel CL; Niehls ME; McGeady SJ; Mansmann HC
J Asthma; 1984; 21(1):35-9. PubMed ID: 6368520
[No Abstract] [Full Text] [Related]
3. Differences in steady-state plasma levels between aminophylline and theophylline sustained-release micropellets after repeated circadian dosing.
Schulz HU; Steinijans VW; Gabel H
Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):621-5. PubMed ID: 6500759
[TBL] [Abstract][Full Text] [Related]
4. [Bioavailability of microcrystalline theophylline (Nuelin) and theophyllamine tablets].
Bakke OM; Apold J
Tidsskr Nor Laegeforen; 1979 Feb; 99(6):319-21. PubMed ID: 371068
[No Abstract] [Full Text] [Related]
5. [Bioavailability of a delayed-action aminophylline preparation].
Regazzi MB; Guarnone E; Bartoli A; Ciardelli L; Piacentini P
Minerva Med; 1985 Mar; 76(13):641-5. PubMed ID: 3991030
[TBL] [Abstract][Full Text] [Related]
6. Comparative pharmacokinetics of theophylline and aminophylline in man.
Aslaksen A; Bakke OM; Vigander T
Br J Clin Pharmacol; 1981 Mar; 11(3):269-73. PubMed ID: 7213528
[TBL] [Abstract][Full Text] [Related]
7. Comparative bio-availability of theophylline whole and halved sustained-release tablets.
Müller FO; Hundt HK; Luus HG; van Dyk M; Groenewoud G; van der Meer MJ; Steinijans VW
S Afr Med J; 1987 Aug; 72(3):175-8. PubMed ID: 3299763
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability of theophylline following a rectally administered concentrated aminophylline solution.
Mason WD; Lanman RC; Amick EN; Arnold J; March L
J Allergy Clin Immunol; 1980 Aug; 66(2):119-22. PubMed ID: 7400475
[TBL] [Abstract][Full Text] [Related]
9. Comparative bioavailability of a microcrystalline theophylline tablet and uncoated aminophylline tablets.
Sansom LN; Milne RW; Cooper D
Eur J Clin Pharmacol; 1979; 16(6):417-21. PubMed ID: 583332
[TBL] [Abstract][Full Text] [Related]
10. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
Schuppan D; Molz KH; Staib AH; Rietbrock N
Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic characteristics of a new sustained-release theophylline capsule with a longer absorption profile: single and multiple dosing bioavailability studies.
Saccar CL; Green LD; Helsel CL; Niehls ME; Diconcetto JA; Mansmann HC; McGeady SJ
Ann Allergy; 1983 Apr; 50(4):245-8. PubMed ID: 6340563
[No Abstract] [Full Text] [Related]
12. Pharmacokinetic studies of theophylline in dogs.
McKiernan BC; Neff-Davis CA; Koritz GD; Davis LE; Pheris DR
J Vet Pharmacol Ther; 1981 Jun; 4(2):103-10. PubMed ID: 7349323
[TBL] [Abstract][Full Text] [Related]
13. Food-induced changes in theophylline absorption from controlled-release formulations. Part I. Substantial increased and decreased absorption with Uniphyl tablets and Theo-Dur Sprinkle.
Karim A; Burns T; Wearley L; Streicher J; Palmer M
Clin Pharmacol Ther; 1985 Jul; 38(1):77-83. PubMed ID: 4006379
[TBL] [Abstract][Full Text] [Related]
14. [Comparative evaluation of human absorption of theophylline and aminophylline in oral and other administration].
Scarpa R; Cima L
Clin Ter; 1969 Aug; 50(4):301-22. PubMed ID: 5382207
[No Abstract] [Full Text] [Related]
15. Absorption of theophylline from conventional and sustained-release tablets.
Fagerström PO; Mellstrand T; Svedmyr N
Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):131-8. PubMed ID: 7228455
[TBL] [Abstract][Full Text] [Related]
16. [Biopharmaceutical evaluation of aminophylline suppositories. I. Pharmacological parameters of theophylline from aminophylline suppositories with normal and prolonged time of total deformation].
Masiakowski J; Cieszyński T; Dyderski S; Perz A
Acta Pol Pharm; 1984; 41(1):99-104. PubMed ID: 6496143
[No Abstract] [Full Text] [Related]
17. Absorption of theophylline from conventional and sustained-release tablets.
Mellstrand T; Svedmyr N; Fagerström PO
Eur J Respir Dis Suppl; 1980; 109():54-60. PubMed ID: 6934088
[TBL] [Abstract][Full Text] [Related]
18. Theophylline versus aminophylline in rectal administration.
Touitou E; Yosselson-Superstine S
J Clin Hosp Pharm; 1985 Jun; 10(2):211-7. PubMed ID: 4019794
[TBL] [Abstract][Full Text] [Related]
19. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels.
Steinijans VW; Zech K; Fischer R
Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):624-30. PubMed ID: 6668100
[TBL] [Abstract][Full Text] [Related]
20. Comparison of theophylline bioavailability from single doses of an elixir and two multi-ingredient tablets.
Dumas WB; Murphy JE; Shleifer NH; Shah VR
Clin Pharm; 1982; 1(4):368-70. PubMed ID: 7185533
[No Abstract] [Full Text] [Related]
[Next] [New Search]
